[1] Amel-Kashipaz MR, Huggins ML, Lanyon P, Robins A, et al. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokineproducing CD8 (-) and CD8 (+) T cells in systemic lupus erythematosus. J Autoimmun, 2001, 17:155-163. [2] Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum,1982, 25:1271-1277. [3] Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35:630-640. [4] Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med, 1994,179:1109-1118. [5] Jonuleit H, Schmitt E, Stassen M, et al. Identification and functional characterization of human CD4 (+) CD25 (+) T cells with regulatory properties isolated from peripheral blood. J Exp Med, 2001, 193:1285-1294. [6] Jinquan T, Quan S, Jacobi HH, et al. Cutting edge:expression of the NF of activated T cells in eosinophils:regulation by IL-4 and IL-5.J Immunol, 1999, 163:21-24. [7] Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell, 1999, 99:23-33. |